• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡那地尔和尼可地尔对克隆的ATP敏感性钾通道的SUR2亚型(A和B)依赖性差异激活。

SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.

作者信息

Shindo T, Yamada M, Isomoto S, Horio Y, Kurachi Y

机构信息

Department of Pharmacology II, Faculty of Medicine, Osaka University, Suita, Japan.

出版信息

Br J Pharmacol. 1998 Jul;124(5):985-91. doi: 10.1038/sj.bjp.0701927.

DOI:10.1038/sj.bjp.0701927
PMID:9692785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1565476/
Abstract
  1. The classical ATP sensitive K+ (K(ATP)) channels are composed of a sulphonylurea receptor (SUR) and an inward rectifying K+ channel subunit (BIR/Kir6.2). They are the targets of vasorelaxant agents called K+ channel openers, such as pinacidil and nicorandil. 2. In order to examine the tissue selectivity of pinacidil and nicorandil, in vitro, we compared the effects of these agents on cardiac type (SUR2A/Kir6.2) and vascular smooth muscle type (SUR2B/Kir6.2) of the K(ATP) channels heterologously expressed in HEK293T cells, a human embryonic kidney cell line, by using the patch-clamp method. 3. In the cell-attached recordings (145 mM K+ in the pipette), pinacidil and nicorandil activated a weakly inwardly-rectifying, glibenclamide-sensitive 80 pS K+ channel in both the transfected cells. 4. In the whole-cell configuration, pinacidil showed a similar potency in activating the SUR2B/Kir6.2 and SUR2A/Kir6.2 channels (EC50 of approximately 2 and approximately 10 microM, respectively). On the other hand, nicorandil activated the SUR2B/Kir6.2 channel > 100 times more potently than the SUR2A/Kir6.2 (EC50 of approximately 10 microM and > 500 microM, respectively). 5. Thus, nicorandil, but not pinacidil, preferentially activates the K(ATP) channels containing SUR2B. Because SUR2A and SUR2B are diverse only in 42 amino acids at their C-terminal ends, it is strongly suggested that this short part of SUR2B may play a critical role in the action of nicorandil on the vascular type classical K(ATP) channel.
摘要
  1. 经典的ATP敏感性钾通道(K(ATP)通道)由磺脲类受体(SUR)和内向整流钾通道亚基(BIR/Kir6.2)组成。它们是被称为钾通道开放剂的血管舒张剂的作用靶点,如吡那地尔和尼可地尔。2. 为了研究吡那地尔和尼可地尔的组织选择性,我们在体外通过膜片钳法比较了这些药物对在人胚肾细胞系HEK293T细胞中异源表达的心脏型(SUR2A/Kir6.2)和血管平滑肌型(SUR2B/Kir6.2)K(ATP)通道的影响。3. 在细胞贴附记录中(电极内液为145 mM K+),吡那地尔和尼可地尔在两种转染细胞中均激活了一种弱内向整流、格列本脲敏感的80 pS钾通道。4. 在全细胞模式下,吡那地尔激活SUR2B/Kir6.2和SUR2A/Kir6.2通道的效力相似(EC50分别约为2 microM和约10 microM)。另一方面,尼可地尔激活SUR2B/Kir6.2通道的效力比激活SUR2A/Kir6.2通道强100倍以上(EC50分别约为10 microM和>500 microM)。5. 因此,尼可地尔而非吡那地尔优先激活含有SUR2B的K(ATP)通道。由于SUR2A和SUR2B仅在其C末端的42个氨基酸上不同,强烈提示SUR2B的这一短片段可能在尼可地尔对血管型经典K(ATP)通道的作用中起关键作用。

相似文献

1
SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.吡那地尔和尼可地尔对克隆的ATP敏感性钾通道的SUR2亚型(A和B)依赖性差异激活。
Br J Pharmacol. 1998 Jul;124(5):985-91. doi: 10.1038/sj.bjp.0701927.
2
Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.磺酰脲受体2B与Kir6.1形成一种对磺酰脲敏感但对ATP不敏感的钾通道。
J Physiol. 1997 Mar 15;499 ( Pt 3)(Pt 3):715-20. doi: 10.1113/jphysiol.1997.sp021963.
3
Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.包含SUR2A或SUR2B亚基的K(ATP)通道对核苷酸和平那地尔的差异反应。
Mol Pharmacol. 2000 Dec;58(6):1318-25. doi: 10.1124/mol.58.6.1318.
4
The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K+ channel expressed in a mammalian cell line, HEK293T cells.核苷酸和钾通道开放剂对在哺乳动物细胞系HEK293T细胞中表达的SUR2A/Kir6.2复合钾通道的影响。
Pflugers Arch. 1998 Apr;435(5):595-603. doi: 10.1007/s004240050559.
5
Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.人阴茎平滑肌细胞中KATP通道的分子基础与特性
Int J Impot Res. 2003 Aug;15(4):258-66. doi: 10.1038/sj.ijir.3901013.
6
Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.新型二氢吡啶钾通道开放剂A-312110与重组磺酰脲受体及KATP通道的相互作用:与氰基胍P1075的比较
Br J Pharmacol. 2004 Apr;141(7):1098-105. doi: 10.1038/sj.bjp.0705718. Epub 2004 Mar 15.
7
Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.KATP通道抑制剂PNU-99963和PNU-37883A的不同分子作用位点。
Br J Pharmacol. 2003 May;139(1):122-8. doi: 10.1038/sj.bjp.0705228.
8
Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.天然线粒体ATP敏感性钾通道与分子定义的表面ATP敏感性钾通道的药理学比较。
Mol Pharmacol. 2001 Feb;59(2):225-30.
9
Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.与内向整流钾离子通道Kir6.1共表达可增加血管磺脲类受体SUR2B对格列本脲的亲和力。
Mol Pharmacol. 1999 Nov;56(5):955-61.
10
Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.大鼠基底动脉和大脑中动脉中K(ATP)通道的特性:血管舒缩反应及mRNA表达的研究
Eur J Pharmacol. 2005 Oct 31;523(1-3):109-18. doi: 10.1016/j.ejphar.2005.08.028. Epub 2005 Oct 13.

引用本文的文献

1
Targeting Host Sulphonyl Urea Receptor 2 Can Reduce Severity of Associated Gastritis.靶向宿主磺酰脲受体2可减轻相关胃炎的严重程度。
Gastro Hep Adv. 2023 Mar 8;2(5):721-732. doi: 10.1016/j.gastha.2023.03.007. eCollection 2023.
2
A novel ABCC9 variant in a Greek family with Cantu syndrome affecting multiple generations highlights the functional role of the SUR2B NBD1.一个希腊家系中存在 Cantu 综合征的新型 ABCC9 变异,影响多个世代,突显了 SUR2B NBD1 的功能作用。
Am J Med Genet A. 2024 Dec;194(12):e63815. doi: 10.1002/ajmg.a.63815. Epub 2024 Jul 19.
3
Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome K Channel Mutations in Intact Cells.快速鉴定完整细胞中 Cantú 综合征钾通道突变的功能和药理学后果。
J Pharmacol Exp Ther. 2023 Sep;386(3):298-309. doi: 10.1124/jpet.123.001659. Epub 2023 Aug 1.
4
CL-705G: a novel chemical Kir6.2-specific K channel opener.CL-705G:一种新型的化学特异性Kir6.2钾通道开放剂。
Front Pharmacol. 2023 Jun 20;14:1197257. doi: 10.3389/fphar.2023.1197257. eCollection 2023.
5
The inhibition mechanism of the SUR2A-containing K channel by a regulatory helix.含 SUR2A 的 K 通道受调节螺旋抑制的机制。
Nat Commun. 2023 Jun 17;14(1):3608. doi: 10.1038/s41467-023-39379-4.
6
Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension.SUR2/Kir6.1通道在肺动脉高压病理生理学中的作用
Front Cardiovasc Med. 2023 Jan 10;9:1066047. doi: 10.3389/fcvm.2022.1066047. eCollection 2022.
7
A Cantú syndrome mutation produces dual effects on KATP channels by disrupting ankyrin B regulation.坎图综合征突变通过破坏锚蛋白 B 的调节对 KATP 通道产生双重影响。
J Gen Physiol. 2023 Jan 2;155(1). doi: 10.1085/jgp.202112995. Epub 2022 Oct 26.
8
Structural identification of vasodilator binding sites on the SUR2 subunit.血管扩张剂结合部位在 SUR2 亚基上的结构鉴定。
Nat Commun. 2022 May 13;13(1):2675. doi: 10.1038/s41467-022-30428-y.
9
Kir6.2-D323 and SUR2A-Q1336: an intersubunit interaction pairing for allosteric information transfer in the KATP channel complex.Kir6.2-D323 和 SUR2A-Q1336:KATP 通道复合物中变构信息传递的亚基间相互作用配对。
Biochem J. 2020 Feb 14;477(3):671-689. doi: 10.1042/BCJ20190753.
10
Genetic Discovery of ATP-Sensitive K Channels in Cardiovascular Diseases.心血管疾病中 ATP 敏感性钾通道的遗传学发现。
Circ Arrhythm Electrophysiol. 2019 May;12(5):e007322. doi: 10.1161/CIRCEP.119.007322.